trimethoprim has been researched along with 5,6,7,8-tetrahydrofolic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McPartlin, J; Quinlivan, EP; Scott, J; Weir, DG | 1 |
| Benedik, MJ; Islam, S; Wood, TK | 1 |
| Cheng, YS; Sacchettini, JC | 1 |
3 other study(ies) available for trimethoprim and 5,6,7,8-tetrahydrofolic acid
| Article | Year |
|---|---|
Mechanism of the antimicrobial drug trimethoprim revisited.
Topics: 4-Aminobenzoic Acid; Anti-Bacterial Agents; Escherichia coli; Folic Acid; Folic Acid Antagonists; Pteridines; Tetrahydrofolates; Trimethoprim | 2000 |
Orphan toxin OrtT (YdcX) of Escherichia coli reduces growth during the stringent response.
Topics: Anti-Bacterial Agents; Antitoxins; Bacterial Toxins; Carbenicillin; Escherichia coli; Escherichia coli Proteins; Sulfamethoxazole; Tetrahydrofolates; Trimethoprim | 2015 |
Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
Topics: Aminosalicylic Acid; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Drug Resistance, Bacterial; Enzyme Inhibitors; Folic Acid Antagonists; Kinetics; Ligands; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; NADP; Nucleotide Deaminases; Phylogeny; Recombinant Proteins; Tetrahydrofolate Dehydrogenase; Tetrahydrofolates; Trimethoprim; Trimetrexate | 2016 |